AmSurg receives ‘buy’ rating — 5 quick facts

Eleven analysts gave AmSurg shares a “buy” rating, according to The Vista Voice.

Advertisement

Here are five quick facts:

1. Analysts have a 12-month price target of $89.78 on AmSurg shares.

2. On April 13, AmSurg shares opened at $76.02.

3. The company’s market cap is $4.07 billion.

4. AmSurg has a 50-day moving average of $72.12 and 200-day moving average of $75.26.

5. The company has a P/E ratio of 24.08.

More articles on surgery centers:
7 new joint venture ASCs — March/April 2016
Stamford ASC opens in Connecticut — 5 highlights
Mercy Health’s plans for outpatient center advance — 5 points

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.